Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of recombinant Lactococcus lactis producing myelin peptides on neuroimmunological changes in rats with experimental allergic encephalomyelitis.
Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
Role of C16, angiopoietin-1 and regeneration gene protein 2 in attenuating inflammation in an experimental rat model of autoimmune encephalomyelitis.
Fampridine and quality of life in individuals with multiple sclerosis.
Microglia: Senescence Impairs Clearance of Myelin Debris.
Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.
Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
Evolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis.
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
Assessing response to interferon-β in a multicenter dataset of patients with MS.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Role of tumor necrosis factor-alpha in zebrafish retinal neurogenesis and myelination.
Imaging biomarkers in multiple Sclerosis: From image analysis to population imaging.
Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.
Poster 224 Giant Cell Myocarditis Masked by Acute Inflammatory Demyelinating Polyneuropathy: A Case Report.
The Impact of MS-Related Cognitive Fatigue on Future Brain Parenchymal Loss and Relapse: A 17-Month Follow-up Study.
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Testing the health promotion model for adherence and quality of life in individuals with multiple sclerosis.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.

Pages